ロード中...
Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs)
Recent clinical trials have led to significant advancements in treatment options for metastatic neuroendocrine tumors of the pancreas. Sunitinib and everolimus have been approved by the Food and Drug Administration for treatment of progressive pancreatic NETs based on phase III trial data demonstrat...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Society of Gastrointestinal Oncology
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3849907/ https://ncbi.nlm.nih.gov/pubmed/24312683 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|